M2698 is an Orally Active, ATP-Competitive, Selective, Dual p70S6K and Akt Inhibitor
The disorder of PI3K/Akt/mTOR (PAM) signaling pathway occurs in about 30% of human cancers, making it a reasonable target for new therapies. Specifically, the pathway is an important regulator of…